Ginkgo Bioworks engineers organisms for customers in biotech, pharma, agriculture, food, and materials using an automated “foundry” and a bio + AI data platform. It offers contract R&D, cloud lab services, and partnerships that can include licensing and royalties on resulting products. Founded in 2008 and headquartered in Boston, it is a public company listed on the NYSE and BMV.